Breaking News
Kleiner Device Labs
About Kleiner Device Labs
Kleiner Device Labs – Advancing Minimally Invasive Spinal Surgery™
During 25 years of active spinal surgical practice and over 6,000 surgeries, Dr. Jeffrey Kleiner became increasingly aware that instrument design and quality played a significant role in the clinical outcome of spinal surgery. He recognized key gaps in the instrumentation available to spinal surgeons and this led him to develop a series of innovative solutions.
In 2013, Dr. Kleiner established Kleiner Device Labs to build and sell innovative spinal surgical products. These novel and advanced tools deliver improvements in efficiency and safety for patients and enable surgeons to perform more effective and less complicated fusion surgery.
Kleiner Device Lab’s first product, a Bi-Directional Graft Funnel (KG™1), works with any flowable biologic graft material, provides a more efficient and safer delivery vehicle for bone graft extenders, facilitates grafting in front of or alongside all types of interbody cages and can eliminate or reduce surgeon dependency on BMP.
Building on the underlying philosophy behind the KG™1, Kleiner Device Labs developed the KG™2 Surge™ Flow-Thru Interbody Implant in 2021. No other device integrates implant positioning and graft delivery like the KG™2 Surge™. The system not only maximizes successful outcomes for patients (while simplifying the procedure for surgeons) but reduces costs for healthcare providers and insurers as well.
Kleiner Device Labs has a broad patent portfolio and a runway of innovative minimally invasive spinal surgical products. These strategies are equally effective in open theater surgical technique as well.